Skip to content
Search

Latest Stories

PM Sunak appoints Steve Barclay as health secretary; moves Therese Coffey to Defra

Prime minister Rishi Sunak appointed Conservative MP for North East Cambridgeshire Steve Barclay as secretary of state for health and social care on 25 October 2022.

He previously held the same role between 5 July and 6 September -- after Sajid Javid resigned as health secretary.


Mr Barclay shared his 'delight' on Twitter.

As head of the Department of Health and Social Care (DHSC) his responsibilities will include "overall financial control and oversight of NHS delivery and performance" as well as "oversight of social care policy".

Mr Barclay was succeeded by Thérèse Coffey, who thanked her "great ministerial team" at the DHSC in a Tweet, before taking up her new responsibility as environment secretary in the new cabinet.

Previously appointed chancellor of the Duchy of Lancaster and minister for the Cabinet Office between 15 September 2021 and July 2022, he was also chief secretary to the Treasury from 13 February 2020 to 15 September 2021; secretary of state for Exiting the European Union from 16 November 2018 to 31 January 2020; and minister of state for the Department of Health and Social Care from January to November 2018 after a stint as economic secretary to the Treasury from June 2017 to January 2018.

The son of a trade union official father and a civil servant mother, Mr Barclay, the youngest of three brothers, came from the first generation of the family to go to university, reading history at at Peterhouse, Cambridge. He later studied law at the College of Law, Chester, qualifying as a solicitor in 1998.

He worked as an insurance company lawyer for Axa Insurance, as a regulator for the Financial Services Authority, and as director of regulatory affairs and then head of anti-money laundering and sanctions at Barclays Retail Bank.

Mr Barclay is married and has two children.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less